Rajesh Kumar
Stock Analyst at HSBC
(4.66)
# 358
Out of 4,479 analysts
18
Total ratings
83.33%
Success rate
18.21%
Average return
Main Sectors:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Upgrades: Buy | $185 | $165.96 | +11.47% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $660 → $670 | $533.93 | +25.48% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $240.41 | +16.47% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $498.24 | -7.68% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical | Initiates: Buy | $13 | $16.55 | -21.45% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $40.45 | +31.03% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $117.07 | -17.14% | 1 | Jul 14, 2023 | |
| BNTX BioNTech SE | Initiates: Buy | $124 | $78.76 | +57.44% | 1 | Jul 14, 2023 | |
| PFE Pfizer | Initiates: Buy | $50 | $27.83 | +79.66% | 1 | Jul 14, 2023 | |
| MRK Merck & Co. | Initiates: Hold | $123 | $127.72 | -3.70% | 1 | Jul 14, 2023 | |
| LLY Eli Lilly | Initiates: Buy | $560 | $906.71 | -38.24% | 1 | Jul 14, 2023 |
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $165.96
Upside: +11.47%
Thermo Fisher
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $533.93
Upside: +25.48%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $240.41
Upside: +16.47%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $498.24
Upside: -7.68%
Teva Pharmaceutical
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $16.55
Upside: -21.45%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $40.45
Upside: +31.03%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $117.07
Upside: -17.14%
BioNTech SE
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $78.76
Upside: +57.44%
Pfizer
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $27.83
Upside: +79.66%
Merck & Co.
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $127.72
Upside: -3.70%
Eli Lilly
Jul 14, 2023
Initiates: Buy
Price Target: $560
Current: $906.71
Upside: -38.24%